U.S. FDA Initiatives to Ensure Drug Supply Chain Integrity

1. Overview

The U.S. drug supply chain remains one of the safest in the world, but has become increasingly complex with global reach. FDA protects consumers from unsafe drugs entering the supply chain via counterfeiting, diversion, theft, or imports of falsified, unapproved, or harmful products. Federal and state laws create a “closed” system; FDA maintains vigilance through oversight, tracing, and enforcement. Source: https://www.fda.gov/drugs/drug-safety-and-availability/drug-supply-chain-integrity

2. Drug Supply Chain Security Act (DSCSA)

DSCSA requires interoperable electronic product tracing at the package level to identify and trace certain prescription drugs. It enhances FDA’s ability to protect against counterfeit, stolen, contaminated, or harmful drugs. Companies must notify FDA within 24 hours of illegitimate products. Source: https://www.fda.gov/drugs/drug-safety-and-availability/drug-supply-chain-integrity

3. Public Education and Professional Guidance

BeSafeRx campaign informs consumers about risks of purchasing prescription medicine from unsafe online pharmacies. Know Your Source program educates healthcare professionals on buying from licensed sources and safe purchasing practices to prevent unsafe or ineffective drugs from harming patients. Source: https://www.fda.gov/drugs/drug-safety-and-availability/drug-supply-chain-integrity

4. Requirements for Industry

Under the Prescription Drug Marketing Act of 1987, manufacturers report significant losses, theft, and falsified prescription drug samples to FDA. Imported drugs must meet FDA standards for quality, safety, and effectiveness. Guidance for industry on anti-counterfeiting using physical-chemical identifiers in solid oral dosage forms. Source: https://www.fda.gov/drugs/drug-safety-and-availability/drug-supply-chain-integrity

5. Domestic and International Engagement

FDA leads creation of the Supply Chain Security Toolkit for Medical Products with Asia Pacific Economic Cooperation. Hosts Online Controlled Substances Summits to reduce illegal online availability of opioids and controlled substances. Collaborates with WHO’s Member State Mechanism on Substandard and Falsified Medical Products. Source: https://www.fda.gov/drugs/drug-safety-and-availability/drug-supply-chain-integrity

6. Reporting and Enforcement Resources

Report supply chain issues to DrugSupplyChainIntegrity@fda.hhs.gov; imports to CDERImports@fda.hhs.gov; exports to CDERexports@fda.hhs.gov. Use MedWatch for product problems; report suspected criminal activity or illegitimate products within 24 hours under DSCSA. Internet pharmacy warning letters and recall coordinator contacts available. Source: https://www.fda.gov/drugs/drug-safety-and-availability/drug-supply-chain-integrity

7. Additional FDA Resources

• Guidance for industry on anti-counterfeiting: https://www.fda.gov/media/116720/download?attachment
• Know Your Source: https://www.fda.gov/drugs/information-health-care-professionals-drugs/know-your-source-protecting-patients-unsafe-drugs
• BeSafeRx: https://www.fda.gov/drugs/quick-tips-buying-medicines-over-internet/besaferx-your-source-online-pharmacy-information
• How to Buy Medicines Safely Online: https://www.fda.gov/consumers/consumer-updates/how-buy-medicines-safely-online-pharmacy Source: https://www.fda.gov/drugs/drug-safety-and-availability/drug-supply-chain-integrity